General News

General News | Nov. 16, 2011

New England Journal of Medicine Publishes Results of Study of CellCept® for Lupus Nephritis

The New England Journal of Medicine published results from a long-term study for the treatment of lupus nephritis.

General News | Nov. 07, 2011

New Study Sheds Light on the Challenges of Developing Lupus Treatments

Lupus Foundation of America Funded Research First to Use Pooled Data from Previous Treatment Trials.

General News | Oct. 31, 2011

Lupus Organizations Around the Globe Urge NICE to Provide Coverage for Benlysta®

National lupus organizations, and individuals with lupus and their families around the world, are rallying to protect access to new treatments of lupus.

General News | Jul. 13, 2011

Health Canada and European Medicines Agency Approves BENLYSTA™

Health Canada and European Regulators have approved BENLYSTA™.

General News | May. 20, 2011

European Review Board Issues Positive Opinion for Benlysta®

The European Medicines Agency’s Committee for Medicinal Products for Human Use has issued a positive opinion, recommending marketing authorisation for BENLYSTA®.

General News | May. 13, 2011

Lupus Foundation of America Presents at National Institutes of Health Lessons in Lupus Event

Dario Dieguez, PhD, from the Lupus Foundation of America joined leading NIH lupus experts to explore current issues in lupus, including risk factors and treatment therapies.

General News | Apr. 13, 2011

Lupus Foundation of America and RN.com Launch New Lupus Education Program

Program provides lupus education to nurses, pharmacists, and pharmacy technicians.

General News | Mar. 09, 2011

LFA Applauds FDA Decision to Approve Benlysta for the Treatment of Lupus

The U.S. Food and Drug Administration (FDA) approved the drug, BENLYSTA®, for the treatment of lupus, an autoimmune disease.